Who invested in Dunad Therapeutics?
Dunad Therapeutics's investors include Novartis.

United Kingdom · Series A startup
Funding summaryUpdated 26 Oct 2026
$38Mraised across 3 rounds since 2021, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Dunad Therapeutics filed 3 raises, $27M in all. Filings say how much was sold and to how many investors; they never name the investors.
Dunad Therapeutics's investors include Novartis.
Dunad Therapeutics has raised $38M across 3 rounds since 2021.
Dunad Therapeutics's most recent round, $547K, was in May 2025.
Dunad Therapeutics's largest round on record is $24M (Series A), in Nov 2021.
Dunad Therapeutics's first round on record, in Nov 2021, was backed by Novartis.
Dunad Therapeutics's latest named round is a Series A, in Nov 2021.
Dunad Therapeutics is based in the United Kingdom.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.